ЕМОЦІЙНА КОМПЕТЕНТНІСТЬ МЕДИЧНОЇ СЕСТРИ ЯК СКЛАДОВА ЇЇ ПРОФЕСІЙНОЇ КОМПЕТЕНТНОСТІ

The article deals with the essence and structure of the concept of  “emotional empathy”. The components of “emotional empathy” in the psychological and pedagogical literature are analyzed. The greater focus is placed on the importance of emotional empathy formation in the context of the professional competence of the nurse.У статті розглянуто сутність та структуру поняття «емоційний інтелект». Опрацьовані складові поняття «емоційний інтелект» у психолого-педагогічній літературі. Акцентовано увагу на важливості формування емоційного інтелекту в контексті професійної компетентності медичної сестри

Optimization models in the SCM-system: progressive supply chain management

Transformations in socio-economic space affect functioning of entrepreneurial activity, leading to a change in the configuration of business processes. In the context of increasing complexity of external environment and digitalization, subjects must ensure the activities effectiveness based on supply chains optimization. Entities are required to use progressive methods of supply chain management. The purpose of the study is to analyze main optimization models in supply chain management (SCM) to determine progressive ways to improve them. The issues of SCM have been worked out, models of their optimization considered and suggestions for their improvement made. Theoretical analysis and generalization of information that allow to substantiate the SCM optimization models’ apparatus (SCOR, DCOR, CCOR) act as a methodological basis. As a result, it is proposed to focus on possibilities of progressive supply chain management, which make it possible to use information technologies to work through a large array of data and continuously obtain values for indicators, contributing to the development of models for optimizing logistics operations and processes in the SCM. The developments obtained are planned to be used for the development of practical models for optimizing enterprises’ supply chains

THE RUSSIAN REGISTRY OF RITUXIMAB. ANALYSIS OF THE EFFICIENCY OF THERAPY AND THE FUNCTIONAL STATEOF PATIENTS WITH RHEUMATOID ARTHRITIS

Objective: To evaluate the functional status of patients with rheumatoid arthritis (RA) receiving two courses of rituximab (RTМ) therapy and its efficiency from the Russian registrys data. Subjects and methods. The analysis covered 269 patients receiving 1 or 2 courses of RT therapy, their clinical follow-up schedules and quality of life (QL) questionnaires were filled in before drug administration and at 8, 16, and 24 weeks of a follow-up: 220 and 49 patients received 1 and 2 courses of RT therapy, respectively. The DAS28 index was used to evaluate disease activity; the patients functional status was assessed according to the Health Assessment Questionnaire (HAQ). Results. The patients' mean age was 46.5311.79 years; the disease duration was 9.806.87 years; disease activity scale (DAS28) scores were 6.501.06; the majority of patients had significant functional disorders estimated at 1.90 [1.37-2.38] scores according to the HAQ; 78% patients had extra-articular manifestations; rheumatoid factor was detected in 82.9%; the patients received more than 2 basic antiinflammatory drugs on average; 33.5% took TNF-р inhibitors. After the first course of therapy at 24 weeks of the follow-up, there was a gradual decline in DAS28 from 6.491.05 to 4.091.32 scores (p < 0.000001, ANOVA). A significant reduction in serum C-reactive protein was achieved during the first course of therapy just at 2 weeks of the follow-up. A decrease in DAS28 to і1.2 was seen in 79.9 of the patients after the first course at 24 weeks of the follow-up and in 85.7% after the second course. 13% of patients achieved drug-induced remission (DAS2

The Role of CYP1A1 Gene Polymorphism in Patients with Erysipelas

© 2017, Springer Science+Business Media, LLC. The research aims are to study the role of CYP1A1 gene polymorphism in predisposition to erysipelas and reveal connections with the clinical course of the disease. We used the standard techniques of molecular genetic analysis. The DNA samples used in genotyping were extracted from leukocytes of venous blood by deproteinization with a phenol-chloroform mixture. Genotyping was performed by polymerase chain reaction (PCR). Statistical data relating to the investigated polymorphic markers were estimated at a 95% confidence level (CL). Genotype frequencies were compared using either the standard Pearson’s chi-squared test or the two-sided Fisher’s exact test. This study presents a comparative analysis of the distribution of gene polymorphisms of cytochrome P450 CYP1A1 (Ile462Val, rs1048943) of phase I detoxification (microsomal oxidation) in the experimental group of 71 patients with erysipelas and a control group of 71 healthy individuals. We also analyzed these relationships of CYP1A1 (Ile462Val) gene polymorphisms with the sex of the patients, the severity and multiplicity of the disease, and the nature of the local process in patients with erysipelas. The results of the investigation indicate the presence of a relationship between cytochrome P450 CYP1A1 (Ile462Val, rs1048943) gene polymorphism and the development of erysipelas. Analysis of these relationships of CYP1A1 (Ile462Val) gene polymorphism with the sex of the patients, the severity and multiplicity of the disease, and the nature of the process in the examined group of patients with erysipelas did not reveal any statistically significant differences

Russian registry of Infliximab.Impact of therapy on the functional status of patients with rheumatoid arthritis

Objective. To evaluate the functional state of rheumatoid arthritis (RA) patients receiving Infliximab therapy (IF) in real clinical practice and its efficiency. Subjects and methods. The analysis covered 225 patients receiving IF therapy, the follow-up duration in whom was 54 weeks. Disease activity was estimated by the DAS 28 index; functional status was assessed according to the Health Assessment Questionnaire (HAQ). The authors made an analysis of a Per-Protocol (PP) population (n = 154) at 54 weeks of treatment and an analysis that could consider the results of treatment (by the ACR and EULAR criteria) in patients who had been withdrawn before the control time - a LOCF (Last Observation Carried Forward analysis) population. Results. The mean age of the patients was 47.6±11.4 years; the duration of the disease was 7.8±6.4 years; DAS 28 activity scores were 6.6±1.1; the majority of patients had significant functional impairments (HAQ scores of 2.0±0.7), 86.7% of the patients had extraarticular manifestations; 79.6% were found to have rheumatoid factor (RF); the patients received an average of > 2 disease-modifying antirheumatic drugs (DMARDs). After 2 week-therapy, there was a reduction in RA activity by DAS 28 index in both the PP (from 6.7±1.1 to 4.0±1.4) and LOCF (6.6±1.1 and 4.2±1.4; p < 106) populations. Drug-induced remission (DAS 28 < 2.6) at 54 weeks was observed in 16.9 and 15.1% of the patients, respectively. Functional improvement was noted in the PP population: HAQ decreased from 2.0±0.7 to 1.7±0.7 scores by week 2; its reduction continued until week 14 (p < 0.05), by remaining stable later on. HAQ dropped from 2.0±0.7 to 1.2±0.7 scores in the LOCF population. At 54 weeks, normal population values of functional activity were achieved in 16.4%. Log regression analysis in the LOCF population indicated that the previous use of DMARDs and a short history of the disease were predictors of an ACR70 response to IF therapy [OR=1.61 (1.13-2.30), p = 0.008 and OR = 0.91 (0.84-0.98), p = 0.018, respectively]. RF seronegativity was a predictor for achievement of low RA activity [OR = 0.44 (0.23-0.84)]. The previous use of glucocorticoids failed to increase the probability of a good response to IF therapy and achievement of clinical remission [OR = 0.26 (0.11-0.60), p = 0.001]. Conclusion. Therapy with IF in combination with methotrexate or other DMARDs reduces RA activity and improves the functional capacities of patients with RA in real clinical practice

Содержание фенольных соединений в листьях Platanthera bifolia из естественной и трансформированных экосистем на разных стадиях развития орхидеи

The representatives of the family Orchidaceae Juss. are often used as a source of natural antioxidants, including phenolic compounds, which play an important role in plant resistance under stressful conditions. This study investigates the content of lipid peroxidation products and soluble phenolic compounds in flowering plants of Platanthera bifolia (L.) Rich. growing in natural (forest park) and transformed (fly ash dumps of Thermal Power Stations) ecosystems of the Middle Urals, Russia, as well as the content of flavonoids at different stages of orchid development. Research has shown that in disturbed habitats, P. bifolia is capable of forming abundant populations containing a significant portion of the flowering plants. Additionally, flowering orchids from fly ash dumps contained an average 20 % more lipid peroxidation products, which indicated a shift in the redox balance towards oxidative processes. An increase by 2.4 times on average in the content of phenolic compounds, particularly flavonoids, was observed at all developmental stages of the plants growing in the transformed ecosystems. Regardless of the growing conditions, the non-flowering mature individuals were characterized by a minimum content of flavonoids, probably due to pre-generative metabolic restructuring. Yet, in the period of orchid blooming, the flavonoid content in their leaves increased again in all study sites. At the same time, the flavonoid proportion of the total soluble phenolic compounds was 42 % in the natural habitat, increasing to 66 % on average in the transformed ecosystems. Thus, flavonoids are involved in the protective adaptive responses of P. bifolia, not only ensuring the survival of this orchid but also contributing to the implementation of its ontogenetic program. © Siberian Federal University. All rights reserved.Acknowledgments. The reported study was partly funded by RFBR and the Government of the Sverdlovsk Region, project number 20-44-660011 and the Ministry of Science and Higher Education of the Russian Federation as part of State Task of the Ural Federal University, FEUZ-2020-0057. The authors are grateful to the reviewers, DSc Pozolotina V.N. (Institute of Plant and Animal Ecology Ural Branch of the RAS, Ekaterinburg) and DSc Dymova O.V. (Institute of Biology of Komi Scientific Centre of the Ural Branch of RAS, Syktyvkar) for valuable comments that helped improve this paper and to Dr. Tripti (Ural Federal University, Ekaterinburg, Russia) for editing of the English language

ЦЕРЕБРАЛЬНЫЕ ВЕНОЗНЫЕ ТРОМБОЗЫ: ВОЗМОЖНОСТИ СОВРЕМЕННЫХ ВЫСОКОТЕХНОЛОГИЧНЫХ МЕТОДОВ ЛУЧЕВОЙ ДИАГНОСТИКИ

The work demonstrates the possibilities of multislice computed tomography (MSCT) and magnetic resonance imaging (MRI) in detecting cerebral venous thrombosis.В работе обсуждаются возможности мультиспиральной компьютерной томографии (МСКТ) и магнитно-резонансной томографии (МРТ) в выявлении церебральных венозных тромбозов

Efficacy and tolerability of abatacept treatment: results of 12 months observation

Objectives: This article reports 1-year clinical outcomes of patients with rheumatoid arthritis (RA) receiving abatacept (ABA) therapy. Materials and methods: Patients (n=91) with high RA activity (DAS28 = 5.1 ± 1.0) and an inadequate response on synthetic DMARDs (mainly methotrexate, 70.3%) and biologics (mainly TNF-α inhibitors, 93%) were included in the study. The majority of patients were middle-aged (49 ± 13.5) womens, RF (72.5%) and ACPA (77%) positive, with moderate functional impairment - HAQ = 1.4 (0.9-2). ABA were administered IV, 10 mg/kg according to the standard scheme. The evaluation of the effectiveness of the therapy was carried out according to the EULAR / ACR 2011 criteria using SDAI, CDAI, HAQ and the intention to treat approach. Results: ABA led to a significant (

Value of ultrasound indices for the assessment of rheumatoid arthritis activity and tocilizumab therapy efficiency

Objective: to estimate the value of simplified ultrasound (US) indices of synovitis in the most commonly involved joints of the dominant hand, which are studied using the grey scale mode while monitoring the efficiency of tocilizumab (TCZ) therapy in patients with rheumatoid arthritis (RA). Subjects and methods. Forty-six patients with RA confirmed by the 1987 American College of Rheumatology (ACR) criteria who had been ineffectively treated received TCZ infusions for 6 months. The patients were stratified into two groups: 1) 11 patients with early (&lt;2-year) RA (ERA); 2) 35 patients with protracted (&gt;2-year) RA (PRA). Disease activity and therapy efficiency were determined by DAS28-CRP, SDAI, and US study of the dominant hand joints most commonly involved in the pathological process. Results. The evaluation of TCZ therapy from the simplified US indices reflected synovitis regression in the dominant hand joints of patients with ERA. The highly significant correlations between the changes in US parameters and RA activity the indices ^US-wrist/iDAS28-CRP: r = 0.75; p = 0.01; ΔUS-S8/ΔDAS28-CRP and ΔUS-S5/ΔSDAI: r = 0.65; p &lt; 0.05) confirm the validity of the above changes. No reduction in the joint indices was observed in the patients with PRA. Conclusion. The simplified grey-scale US indices of synovitis in the joints of the dominant hand (including one wrist joint) is an accessible noninvasive method for evaluating the efficiency of the therapy performed in patients with ERA

EVALUATION OF THE EFFICIENCY OF TOCILIZUMAB THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS BY ULTRASOUND AND X-RAY DATA

Objective: to estimate the time course of changes in the ultrasound signs of wrist joint synovitis in patients with rheumatoid arthritis (RA) during tocilizumab (TCZ) treatment and to determine whether the progression of joint X-ray changes can be predicted by ultrasonography (USG). Subjects and methods. The investigation enrolled 46 patients with the diagnosis of RA that met the American College of Rheumatology 1987 criteria. All the patients were given TCZ during insufficiently effective previous therapy (median DAS28 was 6.7 [range 5.9—7.2]). They were divided into 2 groups: 1) early RA (ERA) with a disease history of less than 2 years (n = 11); 2) RA with a history of over 2 years (n = 35). Hand USG (Voluson-i GE, USA) with a 4—13-MHz linear probe using an energy Doppler (ED) was carried out before and 6 months after therapy. Structural changes were evaluated by hand and foot X-ray study (before and at 12-month follow-up) according to the Sharp method modified by van der Heide. Results. Dynamic evaluation of the ultrasound signs of inflammation indicated a significant reduction in the magnitude of synovitis in accordance with the gray-scale data in both groups and only in the patients with ERA in the ED mode. There was a clear association of the annual increment in joint X-ray changes with the result of estimation of the magnitude of synovitis according to the ED data (r = 0.669; p &lt; 0.01). Conclusion. Wrist joint sonography allows evaluation of the efficiency of the performed therapy in patients with RA and the presence of moderate or severe synovitis, as evidenced by ED, is a predictor for the progression of joint destruction